Committee for Herbal Medicinal Products (HMPC): 18-20 March 2024, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2024 to 20 March 2024

Submitted by Anonymous (not verified) on 12 June 2024 - 9:32

Committee for Herbal Medicinal Products (HMPC): 18-20 March 2024, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2024 to 20 March 2024

Product Management Service (PMS) Product UI training (access & navigation), Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 10:00 (CEST) to 3 June 2024, 11:30 (CEST)

Submitted by Anonymous (not verified) on 12 June 2024 - 8:50

Product Management Service (PMS) Product UI training (access & navigation), Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 10:00 (CEST) to 3 June 2024, 11:30 (CEST)

Human medicines European public assessment report (EPAR): GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.), budesonide,formoterol fumarate dihydrate, Date of authorisation: 03/04/2020, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 11 June 2024 - 14:45

Human medicines European public assessment report (EPAR): GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.), budesonide,formoterol fumarate dihydrate, Date of authorisation: 03/04/2020, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Veltassa, patiromer, Date of authorisation: 19/07/2017, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 11 June 2024 - 10:57

Human medicines European public assessment report (EPAR): Veltassa, patiromer, Date of authorisation: 19/07/2017, Revision: 9, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More